Back to SYRE
Capital International Investors → SYRE
Capital International Investors SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$56.1M
Q3 2026
Peak value
$114.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $114.4M |
| Q1 2026 | $88.1M |
| Q2 2026 | $84.8M |
| Q3 2026 | $56.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $56.1M | 630.4K | — | — |
| Q2 2026 | $84.8M | 955.2K | — | — |
| Q1 2026 | $88.1M | 1.75M | — | — |
| Q4 2025 | $114.4M | 3.49M | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M
$336.7M